Ricardo Gimeno Costa

Dr. Ricardo Gimeno Costa

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
RVRaquel López Vilella
Raquel López Vilella
MGManuel Pérez Guillén
Manuel Pérez Guillén
BCBorja Guerrero Cervera
Borja Guerrero Cervera
RCRicardo Gimeno Costa
Ricardo Gimeno Costa
IZIratxe Zarragoikoetxea
Iratxe Zarragoikoetxea
Luís Almenar-BonetLuís Almenar-Bonet
Luís Almenar-Bonet
Background/Objectives: The direct bridge to urgent heart transplant (HT) with venoarterial extracorporeal membrane oxygenation (VA-ECMO) support has been associated with high morbidity and mortality. The objective of this study is to analyze the morbidity and mortality of patients transplanted with VA-ECMO and compare the presumed differences between various eras over a 17-year timeline. Methods: This is a prospective, observational study on consecutive patients stabilized with VA-ECMO and transplanted with VA-ECMO from July 2007 to December 2023 at a reference center (98 patients). Objective variables were mortality and morbidity from renal failure, venous thromboembolic disease (VTD), primary graft dysfunction (PGD), the need for tracheostomy, severe myopathy, reoperation, post-transplant ECMO, vascular complications, and sepsis/infection. Results: The percentage of patients who reached transplantation without the need for mechanical ventilation has increased over the periods studied. No significant differences were found between the study periods in 30-day mortality (p = 0.822), hospital discharge (p = 0.972), one-year mortality (p = 0.706), or five-year mortality (p = 0.797). Survival rates in these periods were 84%, 75%, 64%, and 61%, respectively. Comorbidities were very frequent, with an average of 3.33 comorbidities per patient. The most frequent were vascular complications (58%), the need for post-transplant ECMO (57%), and myopathy (55%). The development of myopathy and the need for post-transplant ECMO were higher in recent periods (p = 0.004 and p = 0.0001, respectively). Conclusions: VA-ECMO support as a bridge to HT allows hospital discharge for 3 out of 4 transplanted patients. This survival rate has not changed over the years. The comorbidities associated with this device are frequent and significant.

22 April 2022 in Revista Española de Quimioterapia
Verified
Journal Article
Open access
RCRicardo Gimeno Costa
Ricardo Gimeno Costa

12 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
CDCarlos Domínguez-Massa
Carlos Domínguez-Massa
MPManuel Pérez-Guillén
Manuel Pérez-Guillén
IZIratxe Zarragoikoetxea
Iratxe Zarragoikoetxea
ETEduardo Tébar-Botí
Eduardo Tébar-Botí
MDMaría José Dalmau-Sorlí
María José Dalmau-Sorlí
JMJuan Bautista Martínez-León
Juan Bautista Martínez-León
Background/Objectives: This study evaluates the outcomes of extracorporeal membrane oxygenation (ECMO), in venoarterial configuration, and short-term ventricular assist devices (VADs) used as a bridge to heart transplantation (HT). The primary objective was to identify predictors of in-hospital mortality among patients on the urgent HT waiting list receiving short-term mechanical circulatory support, including direct ECMO-to-HT, direct short-term VAD-to-HT, and ECMO as a bridge to short-term VAD followed by HT (ECMO bridge-to-bridge). Secondary objectives included identifying predictors of in-hospital mortality in transplanted patients and assessing their long-term survival. Methods: A single-center, retrospective, observational, and analytical study conducted at a tertiary care hospital, including patients supported with ECMO and short-term VAD support as a bridge to HT between 2007 and 2024. Results: A total of 183 patients were included: 110 in the ECMO-to-HT group, 51 in the VAD-to-HT group, and 22 in the ECMO bridge-to-bridge group. Among them, 147 underwent HT (80.3%). Overall in-hospital mortality was 37.2% (115 of 183 patients survived), while in-hospital mortality among transplanted patients was 21.8% (115 of 147 survived). Independent predictors of in-hospital mortality included infection, ECMO bridge-to-bridge strategy, higher body mass index (BMI), older age, and neurological complications. In the transplanted subgroup, predictors of both in-hospital and long-term mortality were ECMO support and older recipient age. Notably, a donor BMI exceeding that of the recipient by more than 10% was associated with improved survival. Conclusions: The complexity of patients requiring mechanical circulatory support and the physiological effects of different devices necessitate early, individualized management based on the etiology of cardiogenic shock and urgency status.